文献速递美容整形

交联人脱细胞真皮基质在初次与修复性鼻背增高鼻整形术中的有效性

Effectiveness of cross-linked human acellular dermal matrix in primary and revision augmentation rhinoplasty.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-10-22

该回顾性队列研究纳入65个月间由单一术者手术的145例鼻背增高鼻整形术患者,比较交联人脱细胞真皮基质在初次与修复性手术中的效果。两组鼻背高度和鼻根高度均显著改变,但组间无显著差异;患者与术者满意度相当,均无严重并发症。作者认为脱细胞真皮基质可用于初次和修复性鼻背增高,并发症极少。

要点

  • 交联人脱细胞真皮基质在初次与修复性鼻背增高鼻整形中均使鼻背高度和鼻根高度显著改变。
  • 两组间鼻背高度和鼻根高度无显著差异,患者与术者满意度相当。
  • 两组均无严重并发症,取出的脱细胞真皮基质镜下见丰富胶原组织和新形成血管,无异物反应征象。

核心结论

  • 尽管患者特征(年龄、截骨术、鼻尖整形术和鼻背驼峰降低手术数量)存在显著差异,本研究结果提示交联人脱细胞真皮基质可用于初次和修复性鼻背增高鼻整形术,并发症极少。

研究设计与样本

  • 采用回顾性队列研究设计,纳入65个月间由单一术者手术的鼻背增高鼻整形术患者队列,共145例受试者(75.2%为初次鼻背增高,39.3%为女性),平均年龄30.7±9.4岁(范围19-58岁)。
  • 预测变量为治疗分组(初次或修复性鼻背增高鼻整形术),主要结局变量为术后增高程度变化(鼻背高度和鼻根高度与鼻长度的比值)以及患者和术者对美学与功能结果的满意度。

主要发现

  • 鼻背增高鼻整形术在两组均与鼻背高度和鼻根高度的显著变化相关。
  • 两组比较显示鼻背高度和鼻根高度无显著差异。
  • 两手术组的术者和患者满意度相当,两组均未发生严重并发症。
  • 取出的脱细胞真皮基质显微镜检查显示丰富胶原组织伴新形成血管,无异物反应征象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Among the materials used for dorsal augmentation rhinoplasty (DAR), cross-linked human acellular dermal matrix (ADM) has been claimed for its low risk of infection and extrusion. The aim of this study was to compare the effectiveness of ADM in subjects undergoing primary versus revision dorsal augmentation rhinoplasties. METHODS: Using a retrospective cohort study design, the investigators enrolled a cohort set of DAR patients operated by a single surgeon during a 65-month interval. The predictor variable was the treatment group (primary or revision DAR). The main outcome variables were postoperative changes with regard to the degree of augmentation (ratio of the dorsal height [DH] and radix height [RH] to the nasal length) and patients' and surgeons' satisfaction with the aesthetic and functional results. Other study variables were grouped into the following categories: demographic, surgical, and pathological. Descriptive, uni-, and bivariate statistics were computed using P ≤ 0.05 as a cutoff value. RESULTS: The study cohort comprised 145 subjects (75.2% with primary DAR; 39.3% females) with a mean age of 30.7 ± 9.4 years (range, 19-58). DAR was linked to the significant changes in DH and RH in both the treatment groups. Comparison of the two groups revealed that there was no significant difference in DH and RH between both the groups. Surgeons' and patients' satisfaction rates were comparable between the two surgery groups, neither of which experienced serious complications. Microscopic findings of the removed ADM showed abundant collagen tissue with newly formed vessels without signs of foreign body reaction. CONCLUSION: Despite significant differences in patient characteristics (age; number of osteotomy, tip plasty, and hump reduction surgeries), the results of this study suggest that ADM can be used in both primary and revision DAR, with minimal complications.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Park SC, Nam JS, Lee KI, et al. Effectiveness of cross-linked human acellular dermal matrix in primary and revision augmentation rhinoplasty. J Plast Reconstr Aesthet Surg. 2021. PMID: 34955393. doi:10.1016/j.bjps.2021.09.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。